Cargando…
Defining the molecular pathology of pancreatic body and tail adenocarcinoma
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) remains a dismal disease, with very little improvement in survival over the past 50 years. Recent large-scale genomic studies have improved understanding of the genomic and transcriptomic landscape of the disease, yet very little is known about mol...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817249/ https://www.ncbi.nlm.nih.gov/pubmed/29341146 http://dx.doi.org/10.1002/bjs.10772 |